Amlodipine Besylate And Atorvastatin Calcium Tablet, Film Coated
NDC Package 43598-321-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Amlodipine Besylate And Atorvastatin Calcium tablets are indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate. This formulation utilizes a tablet, film coated delivery system. Marketed by Dr. Reddy's Laboratories Inc, this product is identified by NDC 43598-321 and is authorized under FDA application ANDA203874.

Identification & Billing

NDC Package Code
43598-321-30
Package Description
30 TABLET, FILM COATED in 1 BOTTLE
Product Code
43598-321
11-Digit Billing Format
43598032130
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA
RxNorm Crosswalk
  • RxCUI: 404011 - amLODIPine besylate 5 MG / atorvastatin calcium 80 MG Oral Tablet
  • RxCUI: 404011 - amlodipine 5 MG / atorvastatin 80 MG Oral Tablet
  • RxCUI: 404011 - amlodipine (as amlodipine besylate) 5 MG / atorvastatin (as atorvastatin calcium) 80 MG Oral Tablet
  • RxCUI: 404013 - amLODIPine besylate 10 MG / atorvastatin calcium 80 MG Oral Tablet
  • RxCUI: 404013 - amlodipine 10 MG / atorvastatin 80 MG Oral Tablet

Clinical Specifications

Proprietary Name
Amlodipine Besylate And Atorvastatin Calcium
Non-Proprietary Name
Amlodipine Besylate And Atorvastatin Calcium
Substance Name
Amlodipine Besylate; Atorvastatin Calcium Trihydrate
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Amlodipine besylate and atorvastatin calcium tablets are indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate.  Amlodipine

Regulatory & Marketing

Labeler Name
Dr. Reddy's Laboratories Inc
Product Type
Human Prescription Drug
FDA Application #
ANDA203874
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-17-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (43598-321). Click a package code to view its specific billing and regulatory data.

43598-321-05
500 TABLET, FILM COATED in 1 BOTTLE
43598-321-60
60 TABLET, FILM COATED in 1 BOTTLE
43598-321-90
90 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 43598-321-30 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Amlodipine Besylate And Atorvastatin Calcium, a human prescription drug labeled by Dr. Reddy's Laboratories Inc. This tablet, film coated is formulated for oral use and contains amlodipine besylate; atorvastatin calcium trihydrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dr. Reddy's Laboratories Inc on March 17, 2014. The current certification is valid through December 31, 2026.

How is this Dr. Reddy's Laboratories Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 43598032130. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
43598-321-30
11-Digit CMS (5-4-2)
43598-0321-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.